Man Group PLC Bridge Bio Pharma, Inc. Transaction History

Man Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $14.3 Million - $19.2 Million	619,927 New	619,927 $15.7 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $170,542 - $311,619	7,100 New	7,100 $286,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $97,163 - $166,072	-14,416 Reduced 33.46%	28,673 $218,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $173,115 - $269,485	21,803 Added 102.43%	43,089 $429,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $228,307 - $531,986	-43,821 Reduced 67.31%	21,286 $193,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $477,885 - $1.12 Million	65,107 New	65,107 $661,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $213,352 - $292,420	-4,552 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $2.56 Million - $3.53 Million	-55,146 Reduced 92.37%	4,552 $278,000
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $4.34 Million - $5.66 Million	-78,287 Reduced 56.74%	59,698 $3.68 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $535,899 - $992,908	13,963 Added 11.26%	137,985 $9.81 Million
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $169,646 - $263,139	6,237 Added 5.3%	124,022 $4.65 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $2.62 Million - $4.2 Million	117,785 New	117,785 $3.84 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.